Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Matritech (NASDAQ - NMPS) -- Ignore unavailable to you. Want to Upgrade?

To: Bexar who wrote (627)	5/20/1998 9:22:00 AM
From: M.A. Caccavo	Read Replies (4) \| Respond to of 849

well folks.... stock is trading @ 3 in Instinet.

To: Bexar who wrote (627)	5/20/1998 11:51:00 AM
From: Damon Pham	Read Replies (1) \| Respond to of 849

Matritech: Continuing Discussions With FDA >NMPS (Copyright (c) 1998, Dow Jones & Company, Inc.) NEW YORK (Dow Jones)--Shares of Matritech Inc. (NMPS) tumbled 29.7% on heavy volume Wednesday morning after the company said the Food and Drug Administration rejected the company's NuMA test kit for colon cancer. As reported Tuesday, the FDA said the kit failed to meet 510k marketing clearance criteria. In a press release Wednesday, Matritech said the FDA's decision to reject NumMA for for 510(k) marketing clearance "does not imply a decision about the approvability of the product," adding the test is "on track" for approval early in 1999. The Newton, Mass., company said it applied for the 510(k) ruling to speed up marketing clearance for NumMA. The 510(k) clearance is given when a product is found to be substantially similar to another product that has already received FDA clearance. The NuMA test kit is a blood-based assay that uses Matritech's nuclear matrix protein technology for the management of colon-cancer patients. The test kit detects a specific nuclear matrix protein, or NuMA, using antibodies, to differentiate cancerous from normal specimens. Matritech earlier hit a 52-week low of 2 1/2, passing the previous low of 3 3/8 set Jan. 29. Recently, the shares were down 1 3/16 at 2 13/16, on volume of 405,800 shares, compared with the daily average of 58,595.